Disulfidptosis-related lncRNAs for establishing a new prognostic model of endometrial carcinoma and drug sensitivity prediction: A retrospective observational cohort study

Disulfidptosis is a novel mode of regulated cell death, but the prognostic role of disulfidptosis-related lncRNAs (DRLs) in uterine corpus endometrial carcinoma (UCEC) is unclear. Transcriptomic data from 552 UCEC tumor samples and 23 normal samples, together with clinical survival data, were obtained from The Cancer Genome Atlas. DRLs were screened by correlation analysis, Cox regression, and Least Absolute Shrinkage and Selection Operator. A prognostic model was constructed and validated. Functional enrichment, immune infiltration, mutation profiling, and drug sensitivity analyses were performed. A total of 397 DRLs were identified, and a 7-lncRNA signature (AL078644.1, Z99572.1, LINC00645, AC092794.1, AC004596.1, CDKN2B-AS1, AC013486.1) was developed. Patients were stratified into high-risk (n=275) and low-risk (n=264) groups, with significantly poorer survival in the high-risk group (P < .001). The model achieved area under the curve values of 0.781 (1-year), 0.741 (3-year), and 0.706 (5-year), and remained an independent prognostic factor in multivariate analysis (P < .01).Immune profiling revealed P < .05 in CD4+ memory T cells, macrophages M1, and dendritic cells, alongside altered Type I IFN response, APC co-inhibition, and inflammation. Mutation analysis showed distinct distributions of PTEN and TP53 between groups. Enrichment analysis indicated pathways related to microtubule-based movement, extracellular matrix organization, Wnt signaling, and neuroactive ligand-receptor interaction. Drug sensitivity analysis identified 22 compounds with significantly higher sensitivity in the high-risk group. We established a 7-DRL signature that independently predicts UCEC prognosis, reveals immune and molecular heterogeneity, and suggests potential candidate compounds for precision management.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-11-13
DOI
https://doi.org/10.1097/md.0000000000051324
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Disulfidptosis-related lncRNAs for establishing a new prognostic model of endometrial carcinoma and drug sensitivity prediction: A retrospective observational cohort study

Manlin Zhang, Kuiran Liu, Lili Jiang, Weijia Cheng
3 links
Medicine
Cancer-related molecular mechanisms research
article

Disulfidptosis-related lncRNAs for establishing a new prognostic model of endometrial carcinoma and drug sensitivity prediction: A retrospective observational cohort study

Manlin Zhang, Kuiran Liu, Lili Jiang, Weijia Cheng
article en

Abstract

Disulfidptosis is a novel mode of regulated cell death, but the prognostic role of disulfidptosis-related lncRNAs (DRLs) in uterine corpus endometrial carcinoma (UCEC) is unclear. Transcriptomic data from 552 UCEC tumor samples and 23 normal samples, together with clinical survival data, were obtained from The Cancer Genome Atlas. DRLs were screened by correlation analysis, Cox regression, and Least Absolute Shrinkage and Selection Operator. A prognostic model was constructed and validated. Functional enrichment, immune infiltration, mutation profiling, and drug sensitivity analyses were performed. A total of 397 DRLs were identified, and a 7-lncRNA signature (AL078644.1, Z99572.1, LINC00645, AC092794.1, AC004596.1, CDKN2B-AS1, AC013486.1) was developed. Patients were stratified into high-risk (n=275) and low-risk (n=264) groups, with significantly poorer survival in the high-risk group (P < .001). The model achieved area under the curve values of 0.781 (1-year), 0.741 (3-year), and 0.706 (5-year), and remained an independent prognostic factor in multivariate analysis (P < .01).Immune profiling revealed P < .05 in CD4+ memory T cells, macrophages M1, and dendritic cells, alongside altered Type I IFN response, APC co-inhibition, and inflammation. Mutation analysis showed distinct distributions of PTEN and TP53 between groups. Enrichment analysis indicated pathways related to microtubule-based movement, extracellular matrix organization, Wnt signaling, and neuroactive ligand-receptor interaction. Drug sensitivity analysis identified 22 compounds with significantly higher sensitivity in the high-risk group. We established a 7-DRL signature that independently predicts UCEC prognosis, reveals immune and molecular heterogeneity, and suggests potential candidate compounds for precision management.

MedicineVol. 105(46)
Sheng Jing Hospital (CN)
Good health and well-being
Cancer-related molecular mechanisms research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon